Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06009861
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-08-16
Brief Title:
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced OralOropharyngeal Cancer NeoSPOT
Sponsor:
Organization:
Peking University Hospital of Stomatology